688799 Stock Overview
Hunan Warrant Pharmaceutical Co.,Ltd manufactures and sells pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Hunan Warrant Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥47.63 |
| 52 Week High | CN¥52.97 |
| 52 Week Low | CN¥30.02 |
| Beta | 0.26 |
| 1 Month Change | 0.70% |
| 3 Month Change | 16.28% |
| 1 Year Change | 14.83% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.80% |
Recent News & Updates
Shareholder Returns
| 688799 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.3% | 4.9% | 2.1% |
| 1Y | 14.8% | -13.4% | -14.2% |
Return vs Industry: 688799 exceeded the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 688799 exceeded the CN Market which returned -14.6% over the past year.
Price Volatility
| 688799 volatility | |
|---|---|
| 688799 Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688799's share price has been volatile over the past 3 months.
Volatility Over Time: 688799's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,147 | Ben Dong Huang | www.warrant.com.cn |
Hunan Warrant Pharmaceutical Co.,Ltd manufactures and sells pharmaceutical products. It offers medicines in the areas of digestive, berating, anti-infection, gynecology, cardiovascular, cerebrovascular, immunology and nephrology, and other fields. Hunan Warrant Pharmaceutical Co.,Ltd was founded in 2001 and is based in Changsha, China.
Hunan Warrant Pharmaceutical Co.,Ltd Fundamentals Summary
| 688799 fundamental statistics | |
|---|---|
| Market cap | CN¥4.47b |
| Earnings (TTM) | CN¥222.16m |
| Revenue (TTM) | CN¥1.44b |
20.1x
P/E Ratio3.1x
P/S RatioIs 688799 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688799 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.44b |
| Cost of Revenue | -CN¥4.07m |
| Gross Profit | CN¥1.45b |
| Other Expenses | CN¥1.23b |
| Earnings | CN¥222.16m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.37 |
| Gross Margin | 100.28% |
| Net Profit Margin | 15.38% |
| Debt/Equity Ratio | 2.6% |
How did 688799 perform over the long term?
See historical performance and comparison